To improve the efficacy of B7-H3-CAR T-cell therapy in glioblastoma, Huang et al. combined an IL-7-encoding OV (IL-7 OV) with B7-H3-CAR T-cells [77] (Table 2). Here, CD276 is linked to glioblastoma.